Astra Zeneca - which makes the Oxford coronavirus vaccine - says a small study suggests it offers only limited protection against mild disease caused by a variant that emerged in South Africa. The company said it had yet to establish how effective the jab is in preventing severe disease caused by the strain. The BBC's Tim Allman has more.